Login to Your Account

Other News To Note

Tuesday, April 24, 2012

• OrbiMed Advisors, of New York, launched a $222 million fund, OrbiMed Israel Partners LP, to focus on life sciences venture capital opportunities based in Israel. The fund is anchored by an investment from the government of Israel, which also provided special economic terms through the initial tender process for the fund.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription